Patient-first AI Leal Health is a fast-growing patient-centric platform that accelerates access to advanced cancer treatments using AI-powered decision support, presenting a strong value prop for pharma, biotech, and trial sponsors seeking faster patient recruitment and better trial matching.

Clinical trial enablement With capabilities to identify and access trials, recruit patients, and analyze barriers and motivations, Leal offers a compelling channel for sponsors to optimize enrollment, improve retention, and gather real-time analytics on patient flow and trial site performance.

Strategic partnerships Recent collaborations with Summus Global and platform enhancements for genetic data analysis indicate openness to ecosystem partnerships, suggesting expansion opportunities with virtual care platforms, genetic testing providers, and payer networks.

Analytics and insights AI-powered predictive patient journey, analytics programs, and real-time analytics for sponsors and sites provide a basis to offer engagement optimization, recruitment accelerants, and operational efficiency services to clinical research clients.

Growth and reach Recognitions from TIME and Fast Company, along with ongoing platform enhancements and a scalable tech stack, position Leal to expand into additional oncology indications, geographies, and enterprise pharma contracts seeking patient-centric trial solutions.